id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-263391-18x4ann5	Harvey, Ruth	Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus	2019-10-17		.txt	text/plain	3042	134	43	S ince the emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 (1), more than 2,250 laboratory-confirmed cases have been reported to the World Health Organization (WHO); approximately one third of these cases were fatal. The Ministry of Health, Oman; Ministry of Health, Saudi Arabia; and Korea National Institute of Health, South Korea, donated convalescent serum and plasma samples from PCR-confirmed MERS-CoV-infected patients. We included MERS-CoV-negative serum with antibodies against other human coronavirus HCoV-229E, HCoV-NL63, HCoV-OC43, and HCoV-HKU1 (samples 3, 6, 7, 8, 13, 15, and 17) to test specificity of the assays ( Table 2 ). Participants detected pool A, the high-titer MERS-CoV antibody pool (sample 16) in all assays (Table 3) . The low-positive pool (pool C, sample 14) was only detected as positive in a single assay in the study, the Alpha Diagnostic International MERS NP ELISA performed in laboratory 05.	./cache/cord-263391-18x4ann5.txt	./txt/cord-263391-18x4ann5.txt